Q: How do Royal Wolverhampton Hospitals NHS Trust use National Clinical Audit to Achieve Local Service Improvement National Audit – A blunt Instrument Standardised Mortality Ratio Actual Hospital Mortality (%) divided by Expected Mortality (%) = SMR SMR Long Term Trend SMR and Total Patients Treated 1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 0 1994 1996 1998 2000 2002 2004 Dr C E Corbett 2006 2008 2010 2012 2014 Analysis of Standardised Mortality Ratio (S.M.R) Entire Patient Cohort Number of Patients: Mean Score (SD): Mean Risk of Death (SD): Died: Mortality %: SMR: Effective Cost per Survivor: Dr C E Corbett 597 17.0 ( 8.8) 27.8 ( 25.0) 179 29.98 0.98 £7,778.21 Analysis of Standardised Mortality Ratio (S.M.R) Time on Ward > 3 Days Number of Patients: Mean Score (SD): Mean Risk of Death (SD): Died: Mortality %: SMR: Effective Cost per Survivor: Dr C E Corbett 84 20.4 ( 8.4) 39.8 ( 24.1) 38 45.24 1.22 £12,421.96 Action Plan & Introduction of Changes Working closely with the introduction of “Vitalpac”, continued use of Outreach and MEWS it is hoped that patients who would benefit form early ICU admission will be identified more rapidly. This in turn will address the key problem area of delayed ward transfers to ICU. Dr C E Corbett Are we doing the right thing? & Are we doing it right? Clinical Audit in ICU We at New Cross have a history and culture of participation in Local, National & International Audit & Research projects. We have been collecting data since 1994 Daily Patient Flow Weekly Analysis Dr C E Corbett Annual Audit of the Critical Care Unit 2009/2010 New Cross Hospital Private & Confidential An Independent Report Prepared by: Dr T Chang Clinical Audit & Research Department Medical Associated Software House in Association with Dr C E Corbett Clinical Audit Department New Cross Hospital Dr C E Corbett 2009/2010 ICNARC Reason for Admission Discharged Alive Number Died in Unit Mort % Cardiovascular 170 110 60 35.2 Dermatological 2 2 0 0.0 17 16 1 5.9 238 216 22 9.2 81 73 8 9.9 Haematological/Immunological 9 7 2 22.2 Musculoskeletal 5 5 0 0.0 Neurological 50 39 11 22.0 Poisoning 16 16 0 0.0 Endocrine, Metabolic, Thermoregulation Gastrointestinal Genito-Urinary Psychiatric 0 0 0 0.0 Respiratory 216 187 29 13.4 19 16 3 15.8 823 687 136 16.5 Trauma Total 2008/2009 ICNARC Reason for Admission Discharged Alive Number Died in Unit Mort % Cardiovascular 147 85 62 42.1 Dermatological 5 5 0 0.0 15 14 1 6.6 Endocrine, Metabolic, Thermoregulation Gastrointestinal 207 189 18 8.7 Genito-Urinary 81 76 5 6.1 Haematological/Immunological 11 9 2 18.2 8 8 0 0.0 Neurological 42 32 10 23.8 Poisoning 27 25 2 7.4 Psychiatric 0 0 0 0.0 Respiratory 218 177 41 18.8 22 19 3 13.6 783 639 144 18.4 Musculoskeletal Trauma Total Dr C E Corbett 2009/2010 2008/2009 Number Ventilated 319 350 % of Total Admissions 38.7% 44.7% Died In Unit 81 106 Unit Mortality % 25.4% 30.2% No with Completed Hospital Outcome 319 350 Total Died in Hospital 99 125 Hospital Mortality % 31.6% 35.7% SMR: 0.96 0.99 APACHE II Risk of Death (SD) – Survivors 27.4 (20.5) 29.1 (19.8) APACHE II Risk of Death (SD) – Died 44.3 (23.9) 52.3 (20.9) Days Ventilated - Survivors 5.5 5.8 Days Ventilated – Non-Survivors 8.6 8.4 Days in unit - Survivors 11.0 10.2 Days in unit – Non-Survivors 7.5 7.1 Number of Non-Ventilated Patients 506 433 Died in unit 55 38 Unit Mortality % 10.8% 8.8% No with Completed Hospital Outcome 495 433 Total Died in Hospital 79 60 Hospital Mortality % 15.9% 13.8% SMR: 0.45 0.61 APACHE II Risk of Death (SD) – Survivors 15.2 (12.4) 15.4 (12.6) APACHE II Risk of Death (SD) – Died 34.7 (20.2) 35.8 (20.4) Days in Unit - Survivors 4.0 4.0 Days in Unit – Non-Survivors 6.0 6.0 Total Number of Patients 823 783 Dr C E Corbett Conclusion The secret of our success: This is in maintaining the momentum and data integrity of the national audit by utilisation of data set to fuel local audit and management reporting. Dr C E Corbett Q: How do Royal Wolverhampton Hospitals NHS Trust use National Clinical Audit to Achieve Local Service Improvement A: We Don’t We make use of the national audit data to benchmark and measure success and failure of local changes in practice .